В. В. Семиглазов
- Oncology top 10%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Genetics
- Pathology and Forensic Medicine
- Co-authors
- В Г ИвановSemiglazov VfА. А. БожокР. М. ПалтуевG. A. DashyanLev M. BersteinE.K. ZiltsovaОльга Александровна Мельникова
- Topics
- Breast Cancer Treatment Studies (25 papers)Cancer Treatment and Pharmacology (19 papers)Advanced Breast Cancer Therapies (18 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer
- Partner nations
- RussiaUnited StatesGermany
In The Last Decade
В. В. Семиглазов
61 papers receiving 453 citations
Peers
Comparison fields: 5 of 69
- Oncology 345
- Cancer Research 269
- Pulmonary and Respiratory Medicine 102
- Genetics 102
- Pathology and Forensic Medicine 99
Countries citing papers authored by В. В. Семиглазов
This map shows the geographic impact of В. В. Семиглазов's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by В. В. Семиглазов with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites В. В. Семиглазов more than expected).
Fields of papers citing papers by В. В. Семиглазов
This network shows the impact of papers produced by В. В. Семиглазов. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by В. В. Семиглазов. The network helps show where В. В. Семиглазов may publish in the future.
Co-authorship network of co-authors of В. В. Семиглазов
This figure shows the co-authorship network connecting the top 25 collaborators of В. В. Семиглазов. A scholar is included among the top collaborators of В. В. Семиглазов based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with В. В. Семиглазов. В. В. Семиглазов is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 4 | |
| 8 | 3 | |
| 9 | 3 | |
| 10 | 2 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | 2 | |
| 15 | 3 | |
| 16 | 0 | |
| 17 | 1 | |
| 18 | [Adjuvant chemotherapy for breast cancer: search for new ways of planning]. | 1 |
| 19 | 21 | |
| 20 | Скрининг рака молочной железы | 1 |
About В. В. Семиглазов
В. В. Семиглазов is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 83 papers that have together received 505 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (25 papers), Cancer Treatment and Pharmacology (19 papers) and Advanced Breast Cancer Therapies (18 papers). The work is most often cited by research in Cancer Research (269 citations), Oncology (345 citations) and Pathology and Forensic Medicine (99 citations). В. В. Семиглазов has collaborated with scholars based in Russia, United States and Germany. Frequent co-authors include В Г Иванов, Semiglazov Vf, А. А. Божок, Р. М. Палтуев, G. A. Dashyan, Lev M. Berstein, E.K. Ziltsova, Ольга Александровна Мельникова, Alexey Manikhas and Светлана Проценко. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.